Nasdaq · Biological Products, (No Diagnostic Substances) · EDGAR filings (CIK 1850270) · 2 signals · 0 setups · updated Aug 16, 2026
What the filings say Pressure ▼
First time the auditor-facing going-concern language appears: the company itself doubts it can fund 12 months.
Radar 57 (elevated attention) · dilution pressure low · listing risk low · governance risk elevated · runway 15.1 mo · strongest signal: New going-concern flag (Aug 10, 2026)
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Signal timeline
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
Date
Signal
Evidence
Score
Aug 10, 2026
▼New going-concern flag
“going concern periodic” language in 10-Q (10-Q) filed 2026-08-10 filing
68
Jun 30, 2026
▼Negative equity
Stockholders' equity $-883,532,000 as of 2026-06-30 filing
31
Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans